Segall Bryant & Hamill, LLC Galapagos Nv Transaction History
Segall Bryant & Hamill, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Galapagos Nv stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 487,196 shares of GLPG stock, worth $15.2 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
487,196
Previous 501,077
2.77%
Holding current value
$15.2 Million
Previous $14 Million
20.33%
% of portfolio
0.24%
Previous 0.2%
Shares
11 transactions
Others Institutions Holding GLPG
# of Institutions
100Shares Held
15.3MCall Options Held
64.6KPut Options Held
39.6K-
Tang Capital Management LLC San Diego, CA4.15MShares$130 Million6.54% of portfolio
-
Madison Avenue Partners, LP New York, NY2.2MShares$68.7 Million6.96% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.67MShares$52.2 Million4.34% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.42MShares$44.3 Million0.01% of portfolio
-
Prosight Management, LP Dallas, TX1.15MShares$36 Million10.53% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $2.06B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...